Alcon EBITDA 2019-2022 | ALC

Alcon annual and quarterly EBITDA history from 2019 to 2022. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Alcon EBITDA for the quarter ending September 30, 2022 was $0.469B, a 3.53% increase year-over-year.
  • Alcon EBITDA for the twelve months ending September 30, 2022 was $1.942B, a 1.2% increase year-over-year.
  • Alcon 2021 annual EBITDA was $1.8B, a 57.34% increase from 2020.
  • Alcon 2020 annual EBITDA was $1.144B, a 9.85% decline from 2019.
  • Alcon 2019 annual EBITDA was $1.269B, a 7.64% decline from 2018.
Alcon Annual EBITDA
(Millions of US $)
2021 $1,800
2020 $1,144
2019 $1,269
2018 $1,374
Alcon Quarterly EBITDA
(Millions of US $)
2022-09-30 $469
2022-06-30 $525
2022-03-31 $509
2021-12-31 $439
2021-09-30 $453
2021-06-30 $475
2021-03-31 $433
2020-12-31 $558
2020-09-30 $301
2020-06-30 $-67
2020-03-31 $352
2019-12-31 $310
2019-09-30 $351
2019-06-30 $308
2019-03-31 $300
2018-12-31
2018-09-30 $388
2018-06-30 $38
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $37.369B $8.291B
Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $230.517B 25.29
Edwards Lifesciences (EW) United States $50.772B 33.11
STERIS (STE) Ireland $21.864B 27.21
Teleflex (TFX) United States $12.124B 19.67
Fresenius Medical Care AG KGaA (FMS) Germany $11.123B 11.16
Penumbra (PEN) United States $9.913B 2372.91
Globus Medical (GMED) United States $7.951B 40.42
Glaukos (GKOS) United States $2.458B 0.00
Integer Holdings (ITGR) United States $2.435B 19.55
AVANOS MEDICAL, INC (AVNS) United States $1.469B 20.92
Nevro (NVRO) United States $1.410B 0.00
Paragon 28 (FNA) United States $1.346B 0.00
Artivion (AORT) United States $0.566B 0.00